Search results
Results From The WOW.Com Content Network
Roche. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Pantene ( / ˌpænˈtiːn, - ˈtɛn /) [ 1] is an American brand of hair care products now owned by Procter & Gamble. The product line originated in Europe in 1945 by Hoffmann-La Roche of Switzerland, which based the name on panthenol. It started to be introduced in the United States and around the world in 1985 when it was purchased by ...
André Hoffmann (born 31 May 1958) is a Swiss billionaire businessman, environmentalist and philanthropist. The great-grandson of Fritz Hoffmann-La Roche who founded the drug company Roche Holding in 1896, [ 1] he currently is the vice-chairman of the company. [ 2] As of November 2020, his estimated net worth is US$5.71 billion [ 3]
Note: The list includes families who, according to reliable sources, have a combined net worth of 5 billion US dollars and above. Marcus Wallenberg Jr., Jacob Wallenberg (1892–1980), Marcus Wallenberg Sr., Gustaf Oscar Wallenberg, Marc Wallenberg, Peter Wallenberg Sr., Jacob Wallenberg, Peter Wallenberg Jr., Marcus Wallenberg, Raoul Wallenberg.
On 2 May 1895, Hoffmann married Adèle La Roche (1876–1938). It was a common practice in Switzerland for married couples to hyphenate the name to incorporate both surnames, so from this point he was often referred to as Fritz Hoffmann-La Roche. They had two sons, Emmanuel (4 May 1896, Basel – 3 October 1932, Basel) and Alfred (25 July 1898 ...
Pages in category "Drugs developed by Hoffmann-La Roche" The following 138 pages are in this category, out of 138 total. This list may not reflect recent changes .
Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. Tocilizumab was jointly developed by Osaka University and Chugai, and was licensed in 2003 by Hoffmann-La Roche.